Clinical Trials
2 trialsNCT03737994 2026-04-23
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT04030429 2025-07-16
Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer
National Cheng-Kung University Hospital
Phase 2 Terminated